|
TMEM131 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.254200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.780100E-02 |
| Normal-vs-Stage2 |
5.398200E-01 |
| Normal-vs-Stage3 |
8.396800E-01 |
| Normal-vs-Stage4 |
6.450200E-01 |
| Stage1-vs-Stage2 |
3.685200E-01 |
| Stage1-vs-Stage3 |
1.021650E-01 |
| Stage1-vs-Stage4 |
7.506400E-02 |
| Stage2-vs-Stage3 |
6.593600E-01 |
| Stage2-vs-Stage4 |
4.013400E-01 |
| Stage3-vs-Stage4 |
5.833000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.353210E-01 |
| Normal-vs-AfricanAmerican |
4.057200E-01 |
| Normal-vs-Asian |
5.693600E-01 |
| Caucasian-vs-AfricanAmerican |
5.256400E-01 |
| Caucasian-vs-Asian |
1.240190E-01 |
| AfricanAmerican-vs-Asian |
2.586800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.291950E-02 |
| Normal-vs-Female |
1.214010E-01 |
| Male-vs-Female |
1.43119999995722E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.149200E-01 |
| Normal-vs-Extreme_Weight |
5.656300E-03 |
| Normal-vs-Obese |
5.483800E-01 |
| Normal-vs-Extreme_Obese |
8.020200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.075400E-01 |
| Normal_Weight-vs-Obese |
4.495200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.402400E-01 |
| Extreme_Weight-vs-Obese |
1.799940E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.217200E-01 |
| Obese-vs-Extreme_Obese |
2.100800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.829700E-02 |
| Normal-vs-Age(41-60Yrs) |
7.034000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.476160E-02 |
| Normal-vs-Age(81-100Yrs) |
1.433380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.332100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.405800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.781920E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.039300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.552400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.581400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.706500E-02 |
| Normal-VS-Type2 PRCC |
1.489750E-01 |
| Normal-VS-KIRP CIMP |
9.300600E-03 |
| Normal-VS-Unclassified PRCC |
9.422600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.046400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.3381000000029E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.310420E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.607600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.676760E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.786000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.597700E-02 |
| Normal-vs-N1 |
3.705600E-01 |
| Normal-vs-N2 |
1.417990E-01 |
| N0-vs-N1 |
1.240320E-02 |
| N0-vs-N2 |
1.399990E-02 |
| N1-vs-N2 |
5.228200E-01 |
|
|
